File
DOJ
Document DOJ-OGR-00026127
AI Analysis
Summary: On July 12, 2019, Jeffrey Epstein requested a change in his constipation medication from Bisacodyl to Docusate Sodium (Colace). The change was approved and processed by a medical provider at the Metropolitan Correctional Center in New York (NYM).
Significance: This document reveals details about Jeffrey Epstein's medical treatment while incarcerated, specifically a change in his constipation medication.
Key Topics:
Jeffrey Epstein's medical treatment
Medication change for constipation
Prescription modification
Key People:
- Jeffrey Edward Epstein - Inmate receiving medical treatment
- (b)(6); (b)(7)(C) MD - Medical provider/prescriber